Blotter

2017 Hill Day recap

By
April 11, 2017

This past week, the ASBMB held its annual Hill Day, bringing undergraduate students, graduate students, postdoctoral fellows and midcareer researchers to Capitol Hill to discuss federal funding for scientific research with members of Congress and their staffs.

Early Thursday morning Hill Day attendees put on their advocacy hats and descended on Capitol Hill.

And then the meetings began…

This year the ASBMB brought 29 participants to Washington, D.C. (12 ASBMB PAAC members and 17 grad students, undergraduates, and postdocs) representing 33 states and attended close to 90 meetings.

Teams, in most cases, went to nine meetings, often-times back-to-back requiring them to zigzag from the House to the Senate and back again with few opportunities to to catch their breath.

If they did have a chance to grab a bite, they needed to move fast in order to make their next meeting.

All in all, Hill Day was a success.

We thank the trainees and researchers who continue to help make the case for investments in basic research. Participants reported an overwhelming outpouring of support from both sides of the aisle regarding the future of NIH and NSF funding. As we move closer to the end of a continuing resolution on Apr. 28, we will continue to push for proper appropriations bills that not only fund agencies like the NSF and NIH but also show an increased commitment to investing in the future of the scientific enterprise.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Policy

Policy highlights or most popular articles

ASBMB responds to proposal for new health research agency
Blotter

ASBMB responds to proposal for new health research agency

July 27, 2021

Society recommends keeping funding for ARPA-H separate from that of other agencies and developing a unique strategic plan.

Why is the FDA funded in part by the companies it regulates?
Funding

Why is the FDA funded in part by the companies it regulates?

July 4, 2021

The U.S. Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?

ASBMB calls for changes to Title IX policy
Blotter

ASBMB calls for changes to Title IX policy

June 16, 2021

Society urges Department of Education to revise rule created by Trump administration.

Rethinking the NIH review system
Reimagining

Rethinking the NIH review system

June 10, 2021

Proposals for change include a tiered grant funding system, tweaks to scoring and criteria, internal reviews and a continuous submission system.

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire
News

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire

June 9, 2021

Where the coronavirus originated remains a mystery, and the Chinese are bucking demands to let investigators see more.

Two years of the DOJ’s China Initiative
Blotter

Two years of the DOJ’s China Initiative

April 14, 2021

Despite the agency’s intense scrutiny of scientists at academic institutions, few have been convicted, and none has been accused of economic espionage.